Eli Lilly plans to acquire Centessa Pharmaceuticals, which has been conducting a midstage clinical trial of its lead drug.Eli Lilly plans to acquire Centessa Pharmaceuticals, which has been conducting a midstage clinical trial of its lead drug. Drugs (Pharmaceuticals), Mergers, Acquisitions and Divestitures, Narcolepsy, Parasomnias (Sleep Disorders), Clinical Trials, Eli Lilly and Company, Centessa Pharmaceuticals PLC Read More
Eli Lilly Will Buy a Narcolepsy Drug Developer for $6.3 Billion
